In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Exact Sciences Corp.

https://www.exactsciences.com/

Latest From Exact Sciences Corp.

CM Life Sciences II To Combine With Proteomics SomaLogic In Latest SPAC Deal

The SPAC deal between CM Life Sciences II and SomaLogic is valued at $1.25bn.

Financing Deals

PAVmed Plans Spin-Off And Marketing Push For Lucid Diagnostics

Lucid, which markets the EsoGuard test for Barrett’s esophagus, will become a separate public company, either through an IPO or a business combination with a health care SPAC.

M & A Cancer

Exact Sciences Acquires Ashion Analytics To Accelerate Sequencing Technology

The addition of the Arizona-based sequencing lab builds on Exact’s recent license of the TARDIS liquid biopsy technology from TGen.

M & A In Vitro Diagnostics

Guardant Health Launches Liquid Biopsy Test For Detecting Colorectal Cancer Recurrence

Guardant wants to become “one-stop-shop” in the cancer care continuum with the launch of an early-stage colorectal cancer test and planned launch of a tissue-based test.

Launches Research & Development
See All

Company Information

  • Industry
  • Biotechnology
  • Laboratory Testing Services
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Other Names / Subsidiaries
    • Base Genomics
    • Genomic Health, Inc.
    • Paradigm Diagnostics, Inc.
    • Thrive Earlier Detection Corp.
    • Viomics, Inc.
UsernamePublicRestriction

Register